iPPI-DB

Inhibitors of Protein-Protein Interaction Database

Compound 899

Identifiers

  • Canonical SMILES:
    O[C@H]1CCCN(C1)[C@@]1(Cc2cccc(Cl)c2)C(=O)Nc2cc(Cl)ccc12
  • IUPAC name:
    6-chloro-3-[(3-chlorophenyl)methyl]-3-(3-hydroxypiperidin-1-yl)-1H-indol-2-one
  • InChi:
    InChI=1S/C20H20Cl2N2O2/c21-14-4-1-3-13(9-14)11-20(24-8-2-5-16(25)12-24)17-7-6-15(22)10-18(17)23-19(20)26/h1,3-4,6-7,9-10,16,25H,2,5,8,11-12H2,(H,23,26)/t16-,20+/m0/s1
  • InChiKey:
    FPUNOKXIVOUZST-OXJNMPFZSA-N

External links


168318030

External search

Bibliography (1)

Publication Name
Li Chen, Jing Zhang, Zhuming Zhang, Song Yang, F. Hoffmann-La Roche Ag. . Oxindole derivatives as anticancer agents None. 62

Pharmacological data

Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 0 0 0

Targets

PPI family Best activity Diseases MMoA
MDM2-Like / P53 8.43 cancer Inhibition
Physicochemical filters
Descriptor Lipinski's RO5 Veber Pfizer's 3/75
Compliance
MW 390.09 g/mol
HBA 4
HBD 2
HBA + HBD 6
AlogP 4.14
TPSA 52.57
RB 3
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources Biochemical tests Cellular tests PK tests Cytotoxicity tests
1 1 0 0 0
Pharmacological data
Bibliography Name Target Competition Assay type Assay name Cell line Activity type Activity
WO2008034736 62 MDM2
Q00987

Biochemical assay Time-Resolved FRET pIC50 (half maximal inhibitory concentration, -log10) 8.43
Ta Structure Name Drugbank ID
0.5990 SAR-405838 DB12541
0.5663 Benazeprilat DB14125
0.5600 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone DB02058
0.5407 OPC-51803 DB05838
0.5307 Milademetan DB15257
0.5281 Benazepril DB00542
0.5270 Bentiromide DB00522
0.5261 MK-3207 DB12424
0.5222 SLV-334 DB15356
0.5215 Acyline DB11906
0.5170 OPC-14523 DB05422
0.5141 Aripiprazole DB01238
0.5092 Vabicaserin DB12071
0.5089 Diamino-N-[(4S)-5-anilino-4-{[(2S)-2-{[(1R)-1-carboxyethyl]amino}-4-phenylbutanoyl]amino}-5-oxopentyl]methaniminium DB02747
0.5083 Tolvaptan DB06212